Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative
symbol logo$BSX Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $0.62 up 14.81% YoY • Reported revenue of $5.44B up 7.53% YoY • Boston Scientific estimates third quarter 2026 net sales growth of 3 to 5 percent and adjusted EPS of $0.80 to $0.82, with full year 2026 adjusted EPS of $3.28 to $3.32.
2

Price since post

Full Details

Advertisement|Remove ads.